The future of women's health
may begin where few are looking.
VIDA International is a privately held investment company backing exceptional science in undercapitalized markets. We provide patient capital for the technologies improving women's health throughout life — from diagnostics and hormonal care to fertility, maternal health, and preventive medicine.
- 12+
- Focus areas
- 5
- Life stages of care
- 100%
- Self-funded capital
- EE / CE
- Initial geography
Half the population.
A fraction of the attention.
Women's health has historically been treated as a collection of isolated conditions rather than a connected field of medicine.
Reproductive and hormonal health, fertility, pregnancy, menopause, metabolic risk, autoimmune disease, and mental wellbeing are deeply interconnected — yet research, diagnosis, and access to care rarely reflect that.
Women's health is not a vertical within healthcare. It is a lifelong continuum.
Technology for every stage of a woman's life.
Twelve areas where clinical need, scientific opportunity, and undercapitalized markets meet.
- 01
Reproductive health
Diagnostics, treatments, devices, and care models for reproductive and pelvic health.
- 02
Fertility
Improving assessment, preservation, treatment, and access to care.
- 03
Hormonal health
Diagnostics and treatment platforms for endocrine conditions.
- 04
Menopause
Perimenopause diagnosis, symptom management, and personalized treatment.
- 05
Maternal health
Preconception, pregnancy, childbirth, postpartum, and monitoring.
- 06
Gynecological health
Endometriosis, PCOS, fibroids, pelvic pain, and gynecological cancers.
- 07
Diagnostics
Earlier, less invasive, more accurate detection of conditions affecting women.
- 08
Preventive care
Tools that help women understand risk and receive biology-aware care.
- 09
Chronic conditions
Autoimmune, cardiovascular, metabolic, and bone-health conditions.
- 10
Mental health
Evidence-based technologies at the hormonal / psychological intersection.
- 11
Care delivery
Clinical software, telehealth, and infrastructure that widen access.
- 12
Sexual wellbeing
Clinically grounded solutions for pelvic-floor and sexual health.
Women's health changes.
Care should change with it.
- 01
Adolescence
Menstrual health, hormonal development, and early diagnosis.
- 02
Reproductive years
Fertility, contraception, sexual health, and pregnancy planning.
- 03
Pregnancy & postpartum
Maternal monitoring, recovery, lactation, and mental health.
- 04
Peri / menopause
Hormonal transition, symptom management, cardiovascular and bone health.
- 05
Healthy aging
Prevention, mobility, longevity, and quality of life.
Scientific talent is global. Investment attention is not.
Our initial emphasis includes Eastern Europe, Central Europe, the Baltics, and the Balkans — regions with strong scientific education, medical expertise, and resilient founders.
We seek technologies that begin with deep local understanding and grow into internationally relevant companies.
Evidence before attention.
Five principles that shape every investment decision we make.
Meaningful clinical need
Conditions that materially affect women's health and long-term outcomes.
Scientific credibility
Rigorous research, defensible technology, honest about what is unknown.
Respect for complexity
Women's health cannot be reduced to simplified wellness narratives.
Better patient experience
Care that is understandable, accessible, dignified, and responsive.
Long-term potential
Investing with the time required for research, validation, and trust.
Build for the problems medicine has learned to overlook.
We want to hear from founders, researchers, physicians, and engineers building serious solutions for women's health — a diagnostic, treatment, device, platform, laboratory technology, or new model of care.
Teams that can explain
- 01The unmet clinical need
- 02Why current approaches are insufficient
- 03What is scientifically different
- 04What evidence supports it
- 05How it improves the patient experience
- 06The regulatory and commercial pathway
- 07Why your team is uniquely qualified
Patient capital for problems that require patience.
Discover
Relationships across medicine, science, academia, and regional innovation communities.
Understand
Evaluate the science, clinical need, evidence, patient journey, regulation, and team.
Invest
Private capital where conviction is strong and interests are aligned with founders.
Support
Strategic perspective, governance, international positioning, and expert access.
The next important advance in women's health may already exist.
In a laboratory. A clinic. A university. Or in the hands of a founder who has not yet been seen by the right partner.
We are looking.